
Please try another search
Nu Skin Enterprises, Inc. (NYSE:NUS) has been in troubled waters for a while now due to persistent softness in Mainland China, stemming from limited sales meetings. Notably, this was intensified when the COVID-19 outbreak compelled management to put meetings with sales force and customers on hold in the region, per the latest conference call. In fact, management expects the novel coronavirus pandemic to considerably affect the business in the near term.
Clearly, jitters concerning the virus and continued hurdles in Mainland China have been weighing on investors’ sentiments. Shares of Nu Skin have crashed 43.2% so far this year compared with the industry’s decline of 30.3%.
Incidentally, Nu Skin anticipates sales in Mainland China to decline 20-25% for 2020, with the majority of the fall anticipated in the first half. For 2020, management expects overall revenues of $2.17-$2.30 billion compared with $2.42 billion recorded in 2019. Foreign currency fluctuations are likely to affect revenues for 2020 by 1-2%. Further, 2020 earnings are projected to be $2.00-$2.40 per share, indicating a decline from $3.10 delivered in the prior year.
Well, the novel coronavirus has wreaked havoc on the global market, adversely impacting most industries. Companies operating in or sourcing goods from China remain majorly affected. Companies are largely bearing the brunt of soft traffic, store closures and limited hours of operation. Also, cosmetic players like Inter Parfums (NASDAQ:IPAR) are delaying product launches, given the current situation and its chances to persist in the near term at least. Additionally, coronavirus and its deadly spread beyond China have reduced global travel, which is a blow for biggies like Estee Lauder (NYSE:EL) .
Mainland China Headwinds Hurt Q4 Results
Coming back to Nu Skin, this Zacks Rank #5 (Strong Sell) company has long been battling hurdles in the Mainland China region. Notably, revenues and sales leader counts were soft in the region throughout 2019. This resulted from strong negative media coverage of several industries in the region (including food, health and direct-selling industries) and government restrictions on meetings, which play a major role in creating sales leaders.
These stocks provide a compelling case as safe-haven stocks in the face of an escalating trade war. Each company operates within sectors that are relatively resilient to economic...
When the market narrative becomes too widely accepted, excess seems to be created in some areas of the economy as businesses prepare for what’s coming their way. Today’s stock...
Markets are bouncing back as investors bet on technical support, tariff relief, and Germany’s stimulus plans. But with ISM and NFP data ahead, Fed rate cut bets could shift,...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.